Editorial The Management of Acute Haemorrhage
There are few medical emergencies to rival massive haemorrhage, especially that associated with trauma, in demanding rapid mobilisation of co-ordinated and skilful medical, anaesthetic, surgical and diagnostic services. As techniques of resuscitation and surgery improve more patients are surviving major trauma. A major contribution is being made by improved first-aid management and rescue services, especially with greater paramedic training. Trauma patients who would not have survived the time delay in rescue are now arriving at hospitals. Cardiorespiratory and intravenous fluid therapy prior to hospital admission are improving the shock status of patients at the time that expert medical resuscitation commences. There is increasing realisation that a successful outcome following haemorrhagic shock depends on management during the "Golden Hour". Not only is time of the essence, but a skilful, priority-oriented management plan is essential.
In this symposium issue on the management of acute haemorrhage a holistic approach is presented. Preparedness is emphasised, particularly correct assessment of pre-existing defects in the host-defence systems and availability of haemotherapeutic support. In the haemorrhaging patient therapy will be initiated with and proceed alongside diagnostic manoeuvres, and a careful co-ordination of these parallel aspects of management is essential.
The introduction of more powerful diagnostic tools has enabled accurate and rapid diagnosis of the source of blood loss. However, modern diagnostic and therapeutic technology must not be allowed to supplant good clinical medicine. Many a time an experienced clinician has had reason to say "I could have told you that" when important clinical facts have been missed or forgotten, with valuable minutes Anaesthesia alld /nrellsive Care, Vol. 12, "Vo, ], AlIgllst, /984 being lost while unnecessary or hazardous investigations are being performed.
The spectacular advances in diagnosis and therapy, alongside those of blood transfusion, have tended to overshadow the fact that the body has remarkable defence systems directed towards survival and healing after injury. Despite all the advances, medicine is grappling with a poor understanding of the pathophysiology of shock, adult respiratory distress syndrome, sepsis and multisystem failure, complications of homologous blood transfusion and malnutrition. Blunderbus therapy during the "Golden Hour" may be a two-edged sword. With a frustratingly high proportion of patients surviving the initial resuscitation only to die during the ensuing weeks, a critical look at the "life-saving" therapy given during the "Golden Hour" is necessary. Most evidence points to the fact that a patient's dice is cast for or against a successful outcome during this initial phase of the illness, either because of the nature and severity of the initial injury or because the initial therapy has inherent problems.
For this symposium we havt: brought together a wide range of the medical personnel involved in the resuscitation of acutely haemorrhaging patients. The more specialised investigative procedures and surgical interventions should be the subject of separate consideration. The lively discussion, recorded at the time of the meeting at Royal North Shore Hospital, has been published in full as the last section of the symposium. By reporting the debate which occurred the importance of interdisciplinary discussion has been highlighted. The continuing controversies of whole blood versus packed cells, the use of fresh blood, patient needs versus central blood banking policies, and availability and use of platelet concentrates all receive a good airing. At least a better understanding of the issues can be achieved, although definitive answers may not be forthcoming:
Increasing understanding and recognition of the hazards of homologous blood transfusion are rejuvenating interest and research in methods for blood conservation, autologous transfusion and blood substitutes. As alluded to in this symposium, clinicians will have to look seriously at the alternatives to homologous transfusion and it is likely that major advances will occur in this area in the next decade.
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